Zacks Investment Research on MSN
NTRA debuts Zenith Genomics next-gen sequencing test for rare diseases
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...
Genetic testing can play an important role in identifying patients at risk for malignant hyperthermia (MH), guided by ...
About a year ago, the US Food and Drug Administration (FDA) granted premarket approval to AvertD (SOLVD Health), the first genetic test to assess an individual’s risk of developing opioid use disorder ...
Germline testing is a genetic screening that looks for inherited gene mutations found in every cell. It can identify ...
Now, a step forward in genetic testing could help doctors look deeper than ever before to predict a patient's future health. In a series of studies published recently in Bone Marrow Transplantation, ...
Genomics can help to identify people who are more likely to develop glaucoma potentially long before any symptoms of the disease appear. Instead ...
The GPS Mdx test is a 17-gene expression assay performed on prostate biopsy tissue that may identify signals of favorable vs unfavorable pathology.
MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of PROSTOX™ Standard, a new, clinically validated genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results